[Costs of autologous bone marrow transplantation in non-Hodgkin lymphoma and acute leukemia].
OBJECTIVE
To estimate the costs of an autologous bone marrow transplantation (auto BMT) for patients with non-Hodgkin lymphoma and patients with acute lymphoid leukaemia.


METHODS
Cost analysis.


METHODS
Five Dutch hospitals.


METHODS
By means of detailed cost registration forms, interviews with haematologists, research nurses, research analysts and hospital information systems, the costs of auto BMT were estimated.


RESULTS
The costs of an auto BMT were estimated at f 63,400 per patient with non-Hodgkin lymphoma and at f 86,400 for patients with acute leukaemia. The latter patients stayed longer in hospital and needed more intensive isolation care, more blood transfusions and more antibiotics.


CONCLUSIONS
These data are important when the Medical Insurance Board decides on provision for this treatment.
Uyl-de Groot
C A
CA
Erasmus Universiteit, Instituut voor Medische Technology Assessment/Instituut voor Beleid en Management Gezondheidszorg, Rotterdam.
Rutten
F F
FF
D016026:Bone Marrow Transplantation / Q000191:economics*; D003365:Costs and Cost Analysis; D004471:Economics, Nursing; D006801:Humans; D007902:Length of Stay / Q000191:economics; D008228:Lymphoma, Non-Hodgkin / Q000191:economics / Q000628:therapy*; D009426:Netherlands; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000191:economics / Q000628:therapy*; D014182:Transplantation, Autologous / Q000191:economics*
De kosten van autologe beenmergtransplantatie bij non-Hodgkin-lymfoom en acute leukemie.